MedTrace Logo

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

NCT04117048 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2020-04-06

No results posted yet for this study

Summary

This study evaluates the impact of using LabPad® point-of-care to measure International Normalized Ratio (INR) at home on the patient's follow up on vitamine K antagonist (VKA) treatment during 6 months.

Conditions

  • Vitamine K Antagonist (VKA) Treatment
  • International Normalized Ratio (INR) Measure at Home
  • Thromboembolic Pathology

Interventions

DEVICE

LabPad® point-of-care

All at home INR measurements will be performed by the nurse using the LabPad® point-of-care

Sponsors & Collaborators

  • AG2R La Mondiale

    collaborator OTHER

  • AVALUN

    collaborator UNKNOWN

  • Icadom

    collaborator INDUSTRY

  • ORIADE NOVIALE

    collaborator UNKNOWN

  • SIL-LAB INNOVATIONS

    collaborator UNKNOWN

  • TASDA

    collaborator UNKNOWN

  • Medicalps

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-03
Primary Completion
2020-04-03
Completion
2020-04-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04117048 on ClinicalTrials.gov